Evidence map›Paper›PMID 15536124›Full record

ArticleJournal of cell science2004

Characterization of a novel ATR-dependent, Chk1-independent, intra-S-phase checkpoint that suppresses initiation of replication in Xenopus.

M Gloria Luciani, Maren Oehlmann, J Julian Blow

Open access · greenAbstract read
In one paragraph

Article in Journal of cell science, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. ATR/CHK1 inhibitors and cancer therapy.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2018
    Review
  10. Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression inClinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

M Gloria LucianiWellcome Trust Biocentre, University of Dundee, Dow Street, Dundee, DD1 5EH, UK.
Maren Oehlmann
J Julian Blow
Wellcome Trust · GBUniversity of Dundee · GB

Funding

Cancer Research UK A3135
6 · The paper itself

Abstract

In most eukaryotes, replication origins fire asynchronously throughout S-phase according to a precise timing programme. When replication fork progression is inhibited, an intra-S-phase checkpoint is activated that blocks further origin firing and stabilizes existing replication forks to prevent them undergoing irreversible collapse. We show that chromatin incubated in Xenopus egg extracts displays a replication-timing programme in which firing of new replication origins during S phase depends on the continued activity of S-phase-inducing cyclin-dependent kinases. We also show that low concentrations of the DNA-polymerase inhibitor aphidicolin, which only slightly slows replication-fork progression, strongly suppress further initiation events. This intra-S-phase checkpoint can be overcome by caffeine, an inhibitor of the ATM/ATR checkpoint kinases, or by neutralizing antibodies to ATR. However, depletion or inhibition of Chk1 did not abolish the checkpoint. We could detect no significant effect on fork stability when this intra-S-phase checkpoint was inhibited. Interestingly, although caffeine could prevent the checkpoint from being activated, it could not rescue replication if added after the timing programme would normally have been executed. This suggests that special mechanisms might be necessary to reverse the effects of the intra-S-phase checkpoint once it has acted on particular origins.

Indexed as

AnimalsAphidicolinAtaxia Telangiectasia Mutated ProteinsCaffeineCell Cycle ProteinsCell NucleusCheckpoint Kinase 1ChromatinCyclin ADNA ReplicationElectrophoresis, Agar GelEnzyme InhibitorsKineticsMaleNucleic Acid Synthesis InhibitorsProliferating Cell Nuclear AntigenAphidicolinAtaxia Telangiectasia Mutated ProteinsAtr protein, XenopusCaffeineCdc45 protein, mouseCdc45 protein, XenopusCell Cycle ProteinsCheckpoint Kinase 1Chek1 protein, mouseChek1 protein, XenopusChromatinCyclin AEnzyme InhibitorsNucleic Acid Synthesis InhibitorsProliferating Cell Nuclear AntigenProtein KinasesProtein Serine-Threonine KinasesPurinesRoscovitineXenopus Proteins

Identifiers

PMID15536124
PMCPMC2701543
OpenAlexW2166414761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.